Assignee profile:

Berg LLC

City:

Framingham, Massachusetts

Country:

United States

Published Applications:

31

Last publication date:

2023-09-14

Patent Grants:

29

Last grant date:

2025-06-17

Top Inventors for applications by Berg LLC

These are the the leading inventors for applications assigned to Berg LLC:

Recent patent applications by Berg LLC

Berg LLC based in Framingham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-09-14 ✅ Patent 12,329,726 granted on 2025-06-17
US20230285322A1
Human necessities

Biomarkers for Efficacy of Prophylactic Treatments Against Stress-Induced Affective Disorders

#2 | 2022-03-31
US20220096399A1
Human necessities

METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10

#3 | 2021-07-15 ✅ Patent 11,091,447 granted on 2021-08-17
US20210214320A1
Chemistry; metallurgy

UBE2K modulators and methods for their use

#4 | 2020-08-20 ✅ Patent 11,622,948 granted on 2023-04-11
US20200261379A1
Human necessities

Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders

#5 | 2020-05-21 ✅ Patent 11,028,446 granted on 2021-06-08
US20200157630A1
Chemistry; metallurgy

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

#6 | 2020-03-12 ✅ Patent 11,452,699 granted on 2022-09-27
US20200078320A1
Human necessities

Method of treating or preventing tumors of the central nervous system

#7 | 2019-11-14
US20190343847A1
Human necessities

PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D

#8 | 2019-10-10 ✅ Patent 11,224,641 granted on 2022-01-18
US20190307863A1
Human necessities

Enolase 1 (ENO1) compositions and uses thereof

#9 | 2019-10-03 ✅ Patent 11,694,765 granted on 2023-07-04
US20190304566A1
Physics

Interrogatory cell-based assays for identifying drug-induced toxicity markers

#10 | 2019-08-22 ✅ Patent 11,209,422 granted on 2021-12-28
US20190257820A1
Physics

Methods and kits for detection of coenzyme Q10

#11 | 2018-12-27 ✅ Patent 11,305,016 granted on 2022-04-19
US20180369381A1
Human necessities

Vitamin D3 and analogs thereof for treating alopecia

#12 | 2018-12-27 ✅ Patent 11,419,830 granted on 2022-08-23
US20180369164A1
Human necessities

Use of coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa

#13 | 2018-12-13 ✅ Patent 11,298,313 granted on 2022-04-12
US20180353425A1
Human necessities

Methods of treatment of cancer by continuous infusion of coenzyme Q10

#14 | 2018-09-13 ✅ Patent 11,456,054 granted on 2022-09-27
US20180260515A1
Physics

Interrogatory cell-based assays and uses thereof

#15 | 2018-06-21 ✅ Patent 10,759,850 granted on 2020-09-01
US20180171002A1
Chemistry; metallurgy

Filamin A binding proteins and uses thereof

#16 | 2018-05-17 ✅ Patent 11,001,891 granted on 2021-05-11
US20180135129A1
Chemistry; metallurgy

Methods for treating Parkinson's disease

#17 | 2017-08-31 ✅ Patent 10,376,477 granted on 2019-08-13
US20170246125A1
Human necessities

Method of treating or preventing tumors of the central nervous system

#18 | 2017-04-06 ✅ Patent 10,114,013 granted on 2018-10-30
US20170097336A1
Physics

Method for detection of coenzyme Q10

#19 | 2016-09-08 ✅ Patent 10,539,566 granted on 2020-01-21
US20160258958A1
Physics

Use of markers including filamin A in the diagnosis and treatment of prostate cancer

#20 | 2016-06-16 ✅ Patent 10,482,385 granted on 2019-11-19
US20160171383A1
Physics

Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data

#21 | 2015-12-17 ✅ Patent 10,188,708 granted on 2019-01-29
US20150361409A1
Chemistry; metallurgy

Enolase 1 (Eno1) compositions and uses thereof

#22 | 2015-12-17 ✅ Patent 10,188,707 granted on 2019-01-29
US20150359861A1
Human necessities

Enolase 1 (Eno1) compositions and uses thereof

#23 | 2015-08-20 ✅ Patent 10,668,028 granted on 2020-06-02
US20150231091A1
Human necessities

Methods and use of inducing apoptosis in cancer cells

#24 | 2014-10-09 ✅ Patent 10,933,032 granted on 2021-03-02
US20140302014A1
Human necessities

Methods for the treatment of cancer using coenzyme Q10 combination therapies

#25 | 2014-04-10 ✅ Patent 10,352,947 granted on 2019-07-16
US20140100128A1
Physics

Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease

#26 | 2013-10-03 ✅ Patent 10,061,887 granted on 2018-08-28
US20130259847A1
Physics

Interrogatory cell-based assays and uses thereof

#27 | 2013-08-08 ✅ Patent 10,588,859 granted on 2020-03-17
US20130202683A1
Human necessities

Topical formulations having enhanced bioavailability

#28 | 2012-12-20 ✅ Patent 10,973,763 granted on 2021-04-13
US20120321698A1
Human necessities

Inhalable pharmaceutical compositions

#29 | 2011-09-22 ✅ Patent 11,400,058 granted on 2022-08-02
US20110229554A1
Human necessities

Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof

#30 | 2011-05-12 ✅ Patent 10,519,504 granted on 2019-12-31
US20110110914A1
Chemistry; metallurgy

Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

#31 | 2011-02-03 ✅ Patent 10,365,279 granted on 2019-07-30
US20110027811A1
Physics

Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy

Also check out Berg LLC's (Framingham, United States) applicant profile with 22 patent applications submitted.

AssigneeID:

143189 ⎘